ZHONGTAI SECURITIES·2026-01-26 11:06Investment Rating - The report assigns an "Overweight" rating for the health insurance industry, indicating a positive outlook for the sector in the next 6 to 12 months [11]. Core Insights - The report highlights the importance of the health insurance sector in supporting China's health strategy, with multiple institutions collaborating to enhance product offerings and data capabilities [5][6]. - The shift from passive reimbursement to proactive engagement in commercial health insurance is emphasized, with the establishment of standardized terms and drug payment lists to stabilize market expectations [5]. - The report notes that the commercial health insurance sector is expected to see significant growth, particularly in the area of innovative drug payments, with a projected total compensation amount of approximately 14.7 billion yuan for innovative drugs in 2025 [5]. Summary by Sections Industry Overview - The health insurance industry is experiencing a transformation, with a focus on high-quality development and collaboration among various institutions [5]. - The total market capitalization of the industry is reported at 34,888.11 billion yuan, with the same figure for circulating market capitalization [3]. Market Trends - The report indicates that commercial medical insurance is entering a phase of refinement, with efforts to standardize product designs and payment lists to enhance industry competitiveness [5]. - The establishment of a new data infrastructure for health insurance is being prioritized to improve risk management and operational efficiency [5]. Company Strategies - Major insurance companies are diversifying their health insurance offerings, with each company focusing on different operational models to enhance their service ecosystems [10]. - The report identifies key players such as China Life, China Ping An, and China Pacific Insurance, highlighting their unique approaches to health insurance and the integration of health management services [10]. Investment Recommendations - The report suggests a continued focus on leading insurance companies, including China Life, China Pacific, and AIA, as they are expected to benefit from the ongoing developments in the health insurance sector [5].